Home › Funds › ORBIMED ADVISORS LLC › ARGX
ORBIMED ADVISORS LLC position in ARGX
ARGENX SE · Health Care
ORBIMED ADVISORS LLC reported holding 92,880 shares of ARGX (ARGENX SE) in its Q2 2026 13F filing — a position valued at US$86.2M, representing 1.73% of its reported portfolio and ranking #12 among its reported holdings. ORBIMED ADVISORS LLC has disclosed ARGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How ORBIMED ADVISORS LLC's ARGX position evolved
ORBIMED ADVISORS LLC first disclosed a stake in ARGX in Q3 2023 at 32,600 shares (US$16.0M). The position peaked in Q3 2025 at 172,300 shares, worth US$127.1M. Across 12 filings, ORBIMED ADVISORS LLC increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 92,880 shares valued at US$86.2M — a reduction of -44,020 shares quarter over quarter.. Notable position changes include a 160% increase in Q4 2023 (shares rose 3% over the following quarter), a 79% increase in Q1 2024 (shares rose 9% over the following quarter), a 38% increase in Q2 2024 (shares rose 26% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 32.60K | $16.03M | New |
| Q4 2023 | 84.60K | $32.18M | Add |
| Q1 2024 | 151.60K | $59.69M | Add |
| Q2 2024 | 209.10K | $89.92M | Add |
| Q3 2024 | 204.50K | $110.86M | Reduce |
| Q4 2024 | 189.70K | $116.67M | Reduce |
| Q1 2025 | 206.70K | $122.34M | Add |
| Q2 2025 | 208.00K | $114.65M | Add |
| Q3 2025 | 172.30K | $127.08M | Reduce |
| Q4 2025 | 146.00K | $122.78M | Reduce |
| Q1 2026 | 136.90K | $99.97M | Reduce |
| Q2 2026 | 92.88K | $86.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ARGX and 13F data
ARGX (ARGENX SE) is a Health Care company. 39 other funds we track also report a position in ARGX — the largest reported positions include Jupiter Topco LLC (US$2.30B), Janus Henderson Group (US$1.85B), Artisan Partners Limited Partnership (US$1.40B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ARGX
- Jupiter Topco LLC 2.47M sh · $2.30B · Q2 2026
- Janus Henderson Group 2.54M sh · $1.85B · Q1 2026
- Artisan Partners Limited Partnership 1.51M sh · $1.40B · Q2 2026
- Avoro Capital Advisors LLC 1.00M sh · $927.77M · Q2 2026
- RTW INVESTMENTS, LP 709.45K sh · $658.20M · Q2 2026
- Bellevue Group AG 301.00K sh · $279.26M · Q2 2026
- SANDS CAPITAL MANAGEMENT, LLC 298.60K sh · $277.03M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 264.62K sh · $245.49M · Q2 2026
- Checkpoint Capital L.P. 131.28K sh · $121.80M · Q2 2026
More on ORBIMED ADVISORS LLC
FAQ
How long has ORBIMED ADVISORS LLC held ARGX?
ORBIMED ADVISORS LLC has disclosed ARGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is ORBIMED ADVISORS LLC's current position in ARGX?
As of Q2 2026, ORBIMED ADVISORS LLC holds 92.88K shares of ARGX (ARGENX SE), valued at $86.17M, representing 1.73% of its reported portfolio and ranking #12.
Has ORBIMED ADVISORS LLC been buying or selling ARGX?
In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in ARGX. The position peaked in Q3 2025 at 172.30K shares.
Which other funds hold ARGX?
Other major institutional holders of ARGX include Jupiter Topco LLC, Janus Henderson Group, Artisan Partners Limited Partnership, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.